Healthcare Technology Report September 11, 2024
Eli Lilly and Company has announced the opening of the Lilly Seaport Innovation Center (LSC) in Boston’s Seaport district, a state-of-the-art facility dedicated to advancing RNA and DNA-based therapies and discovering new drug targets. The 346,000-square-foot, 12-story building, developed by Alexandria Real Estate Equities, Inc., will house around 500 Lilly scientists and researchers, alongside 200 professionals from partner companies within Lilly Gateway Labs. The LSC will focus on addressing major disease areas such as diabetes, obesity, cardiovascular conditions, neurodegeneration, and chronic pain, fostering a collaborative environment to...
Today's Sponsors
Today's Sponsor